British American Tobacco (BTI) AI Stock Analysis

• Market Cap: $135.25B
• Dividend Yield: 5.22%
• Average Volume (3M): 5.18M
• Price to Earnings (P/E): 13.5
• Beta (1Y): 0.03
• Revenue Growth: 0.48%
• EPS Growth: N/A
• Country: US
• Employees: 48,989
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Tobacco
• EPS (TTM): 2.55
• Shares Outstanding: 2,174,828,900
• 10 Day Avg. Volume: 4,891,003
• 30 Day Avg. Volume: 5,178,656
• PEG Ratio: 0.08
• Price to Book (P/B): 1.92
• Price to Sales (P/S): 3.59
• P/FCF Ratio: 15.87
• Enterprise Value/Market Cap: 0.98
• Enterprise Value/Revenue: 5.16
• Enterprise Value/Gross Profit: 6.18
• Enterprise Value/Ebitda: 10.48
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 4.88
• Revenue Forecast (FY): $35.66B

• Rating: 69 Neutral
• Price Target: $65.00 ▲(14.02% Upside)
• Action: Reiterated Date: 02/18/26
• Date: Action: Reiterated 02/18/26

BTI scores solidly due to improving profitability and constructive earnings-call outlook on savings, deleveraging and shareholder returns, supported by attractive valuation (moderate P/E and high yield). The score is held back mainly by financial volatility (notably the 2023 loss) and a sharp 2025 decline in operating/free cash flow, while technicals indicate a longer-term uptrend but neutral near-term momentum.

Positive Factors

New Category (Modern Oral) Leadership

Rapid, large-scale Modern Oral growth shows BAT leading a durable structural shift away from combustible products. Category leadership and strong Velo adoption expand addressable market, diversify revenue and offer higher-margin, faster-growth streams that can sustain midterm top-line and profit improvement.

Productivity & Fit2Win Savings

Material, multi-year productivity programs provide durable margin expansion and cashflow tailwinds. Committed GBP2bn target and phased Fit2Win savings create structural cost flexibility to fund innovation, shareholder returns and deleveraging even if revenue growth is lumpy.

Cash Generation & Capital Returns

Consistent ability to generate cash and a clear capital-allocation framework underpin durable shareholder returns and balance-sheet repair. Targets for large cumulative free cash flow and ongoing buybacks/dividends signal structural emphasis on converting earnings into returns and lower leverage.

Negative Factors

Meaningful Leverage

Sustained elevated debt levels reduce strategic and financial flexibility and raise refinancing and interest-rate vulnerability. Even with deleveraging targets, meaningful leverage constrains investment pacing into New Categories and increases downside risk if cash flow weakens or regulatory shocks occur.

Worsening Cashflow Trajectory

A sharp decline in free and operating cash flow undermines a key structural strength: the ability to fund capex, buybacks and deleveraging from internal cash. If the deterioration persists it will pressure the dividend/buyback cadence and slow progress toward stated net-debt targets.

Regulatory, Illicit & Regional Headwinds

Sustained illicit activity and adverse fiscal/regulatory changes in key markets create structural revenue and profitability headwinds. These pressures can depress new-category adoption, necessitate higher compliance/marketing spend, and make returns in affected regions harder to predict over the medium term.

British American Tobacco Business Overview & Revenue Model

Company Description

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

How the Company Makes Money

British American Tobacco generates revenue primarily through the sale of its tobacco products, which include cigarettes and other tobacco items. The company's key revenue streams consist of traditional combustible cigarettes, which remain the largest segment, and a growing range of reduced-risk products such as vaporizers and heated tobacco products, which are gaining popularity among consumers seeking alternatives to smoking. Additionally, BAT generates income from its investments in various subsidiaries and strategic partnerships focused on product development and distribution. The company also focuses on operational efficiency and cost management to enhance profitability. Significant factors contributing to its earnings include brand loyalty, market share in various regions, and the ongoing shift in consumer preferences towards less harmful alternatives, which BAT is actively working to capitalize on through innovation and marketing strategies.

British American Tobacco Financial Statement Overview

Summary

Profitability rebounded strongly in 2025 after a large 2023 loss, but earnings volatility lowers confidence. Leverage remains meaningful and equity/assets have trended down versus 2022, partially offset by some debt reduction. Operating cash flow and free cash flow stayed positive, yet both declined sharply in 2025, creating a near-term cash trajectory risk.

Income Statement

Revenue has been broadly stable with modest growth in 2025 (up ~5.5% year over year) after declines in 2023–2024. Profitability is generally strong for the industry (high gross profit base and solid EBITDA), but results have been volatile: 2023 showed a large net loss, followed by a recovery to profitability in 2024 and much stronger earnings in 2025. Overall, the earnings power looks good, but the size of the 2023 drawdown reduces confidence in consistency.

Balance Sheet

Leverage is meaningful: total debt remains high (~$35–$44B over the period) versus equity (~$48–$75B), implying moderate debt reliance. Equity has trended down from 2022 to 2025, and total assets are also lower versus 2022, which limits balance-sheet flexibility. Offsetting this, the company still retains a sizeable equity base and has reduced debt versus 2022–2023 levels, supporting a mid-range balance-sheet assessment.

Cash Flow

Cash generation is a core strength, with consistently positive operating cash flow and free cash flow across all years shown. However, free cash flow has weakened recently—down ~7% in 2024 and sharply down in 2025 (about -33% year over year), and operating cash flow also fell materially in 2025 versus 2024. The business still converts earnings to cash well in normal years, but the recent decline in cash flow trajectory is a notable risk.

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	25.61B	25.87B	27.28B	27.66B	25.68B
Gross Profit	21.38B	21.43B	22.39B	22.85B	21.09B
EBITDA	11.76B	7.74B	13.28B	12.23B	11.19B
Net Income	7.76B	3.07B	-14.37B	6.67B	6.80B
Balance Sheet
Total Assets	109.29B	118.90B	118.72B	153.55B	137.37B
Cash, Cash Equivalents and Short-Term Investments	3.84B	5.81B	2.96B	4.03B	3.27B
Total Debt	35.07B	36.95B	39.73B	43.14B	39.66B
Total Liabilities	61.15B	68.90B	65.78B	77.84B	69.96B
Stockholders Equity	47.93B	49.64B	52.57B	75.37B	67.10B
Cash Flow
Free Cash Flow	5.79B	9.52B	10.25B	9.87B	9.19B
Operating Cash Flow	6.34B	10.13B	10.71B	10.39B	9.72B
Investing Cash Flow	1.39B	1.38B	-296.00M	-705.00M	-1.14B
Financing Cash Flow	-8.76B	-10.63B	-9.31B	-8.88B	-8.75B

British American Tobacco Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 57.01
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BTI, the sentiment is Positive. The current price of 57.01 is below the 20-day moving average (MA) of 61.25, below the 50-day MA of 58.61, and above the 200-day MA of 53.00, indicating a bullish trend. The MACD of 1.04 indicates Negative momentum. The RSI at 63.14 is Neutral, neither overbought nor oversold. The STOCH value of 90.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BTI.

British American Tobacco Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RLX	76 Outperform	$2.95B	27.91	4.71%	0.35%	51.49%	21.43%
PM	75 Outperform	$290.83B	25.72	―	3.59%	7.72%	-12.45%
BTI	69 Neutral	$135.25B	13.54	15.94%	5.22%	0.48%	―
TPB	69 Neutral	$2.61B	48.23	22.54%	0.28%	6.71%	8.16%
MO	66 Neutral	$115.43B	16.77	―	7.02%	-0.96%	-11.42%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
UVV	56 Neutral	$1.34B	15.87	5.81%	6.15%	3.01%	-7.14%